-+ 0.00%
-+ 0.00%
-+ 0.00%

Cantor Fitzgerald Maintains Neutral on Amgen, Raises Price Target to $465

Benzinga·11/04/2026 12:08:07
Cantor Fitzgerald analyst Carter Gould maintains Amgen (NASDAQ:AMGN) with a Neutral and raises the price target from $440 to $465.